<DOC>
	<DOCNO>NCT00434746</DOCNO>
	<brief_summary>The purpose study assess safety tolerability ascend single IV dose ILV-094 ( investigational drug ) one SC dose ILV-094 healthy subject .</brief_summary>
	<brief_title>Study Safety , Tolerability , PK , PD ILV-094 Administered IV SC Healthy Subjects</brief_title>
	<detailed_description>This randomize , double-blind , placebo-controlled , inpatient/outpatient , sequential-group study ascend single IV dose ILV-094 administer healthy Japanese male subject .</detailed_description>
	<criteria>Men age 20 45 year inclusive screening . Body mass index range 17.6 26.4 kg/m2 body weight &gt; 45 . Nonsmoker smoker few 10 cigarette per day . Must abstain smoke inpatient stay . Healthy determine investigator basis screen evaluation .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>July 2009</verification_date>
</DOC>